Lord, Abbett & Co’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $43.2M | Sell |
|
|||||
|
2024
Q3 | $46M | Sell |
|
|||||
|
2024
Q2 | $43.4M | Buy |
|
|||||
|
2024
Q1 | $32.7M | Sell |
|
|||||
|
2023
Q4 | $55.4M | Buy |
|
|||||
|
2023
Q3 | $34M | Sell |
|
|||||
|
2023
Q2 | $81.9M | Buy |
|
|||||
|
2023
Q1 | $38.1M | Sell |
|
|||||
|
2022
Q4 | $47M | Sell |
|
|||||
|
2022
Q3 | $93.9M | Buy |
|
|||||
|
2022
Q2 | $106M | Sell |
|
|||||
|
2022
Q1 | $121M | Sell |
|
|||||
|
2021
Q4 | $112M | Buy |
|
|||||
|
2021
Q3 | $77.8M | Sell |
|
|||||
|
2021
Q2 | $87.6M | Buy |
|
|||||
|
2021
Q1 | $72M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $2.52M | Sell |
|
|||||
|
2016
Q1 | $4.21M | Sell |
|
|||||
|
2015
Q4 | $10M | Buy |
|
|||||
|
2015
Q3 | $5.45M | Buy |
|